BOSENTAN, A NON-SPECIFIC ENDOTHELIN ANTAGONIST, STIMULATES FRACTURE HEALING
BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS, cilt.19, sa.1, ss.37-46, 2007 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 19 Sayı: 1
- Basım Tarihi: 2007
- Doi Numarası: 10.1142/s1016237207000045
- Dergi Adı: BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.37-46
- Hacettepe Üniversitesi Adresli: Evet
Özet
It is assumed that bosentan, a non-selective ET-1 receptor antagonist, will enhance fracture healing. The aim of this prospective randomized controlled study was to investigate the effects of transcutaneous bosentan administration into diaphyseal bone fractures using radiology, histology, prostaglandin E-2 (PGE(2)) and leukotrien C-4 (LTC4) activity measurements.